These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 31759091)
1. Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome. Eguchi A; Fukuda S; Kuratsune H; Nojima J; Nakatomi Y; Watanabe Y; Feldstein AE Brain Behav Immun; 2020 Feb; 84():106-114. PubMed ID: 31759091 [TBL] [Abstract][Full Text] [Related]
2. Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study. Giloteaux L; O'Neal A; Castro-Marrero J; Levine SM; Hanson MR J Transl Med; 2020 Oct; 18(1):387. PubMed ID: 33046133 [TBL] [Abstract][Full Text] [Related]
3. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls. Giloteaux L; Li J; Hornig M; Lipkin WI; Ruppert D; Hanson MR J Transl Med; 2023 May; 21(1):322. PubMed ID: 37179299 [TBL] [Abstract][Full Text] [Related]
4. Circulating extracellular vesicles as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis: an exploratory pilot study. Castro-Marrero J; Serrano-Pertierra E; Oliveira-Rodríguez M; Zaragozá MC; Martínez-Martínez A; Blanco-López MDC; Alegre J J Extracell Vesicles; 2018; 7(1):1453730. PubMed ID: 29696075 [TBL] [Abstract][Full Text] [Related]
5. Dysregulation of extracellular vesicle protein cargo in female myalgic encephalomyelitis/chronic fatigue syndrome cases and sedentary controls in response to maximal exercise. Giloteaux L; Glass KA; Germain A; Franconi CJ; Zhang S; Hanson MR J Extracell Vesicles; 2024 Jan; 13(1):e12403. PubMed ID: 38173127 [TBL] [Abstract][Full Text] [Related]
6. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study. Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133 [TBL] [Abstract][Full Text] [Related]
7. Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Domingo JC; Cordobilla B; Ferrer R; Giralt M; Alegre-Martín J; Castro-Marrero J Antioxid Redox Signal; 2021 Jun; 34(18):1420-1427. PubMed ID: 33353469 [TBL] [Abstract][Full Text] [Related]
8. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women. Milrad SF; Hall DL; Jutagir DR; Lattie EG; Ironson GH; Wohlgemuth W; Nunez MV; Garcia L; Czaja SJ; Perdomo DM; Fletcher MA; Klimas N; Antoni MH J Neuroimmunol; 2017 Feb; 303():43-50. PubMed ID: 28038892 [TBL] [Abstract][Full Text] [Related]
9. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546 [TBL] [Abstract][Full Text] [Related]
10. Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome. Landi A; Broadhurst D; Vernon SD; Tyrrell DL; Houghton M Cytokine; 2016 Feb; 78():27-36. PubMed ID: 26615570 [TBL] [Abstract][Full Text] [Related]
11. Comparative Analysis of Extracellular Vesicles in Patients with Severe and Mild Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Bonilla H; Hampton D; Marques de Menezes EG; Deng X; Montoya JG; Anderson J; Norris PJ Front Immunol; 2022; 13():841910. PubMed ID: 35309313 [TBL] [Abstract][Full Text] [Related]
12. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin. Maes M; Twisk FN; Kubera M; Ringel K J Affect Disord; 2012 Feb; 136(3):933-9. PubMed ID: 21975140 [TBL] [Abstract][Full Text] [Related]
13. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Maes M; Twisk FN; Ringel K Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). de Vega WC; Herrera S; Vernon SD; McGowan PO BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836 [TBL] [Abstract][Full Text] [Related]
15. Circulating miRNAs Expression in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Soffritti I; Gravelsina S; D'Accolti M; Bini F; Mazziga E; Vilmane A; Rasa-Dzelzkaleja S; Nora-Krukle Z; Krumina A; Murovska M; Caselli E Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445763 [TBL] [Abstract][Full Text] [Related]
16. Data-independent LC-MS/MS analysis of ME/CFS plasma reveals a dysregulated coagulation system, endothelial dysfunction, downregulation of complement machinery. Nunes M; Vlok M; Proal A; Kell DB; Pretorius E Cardiovasc Diabetol; 2024 Jul; 23(1):254. PubMed ID: 39014464 [TBL] [Abstract][Full Text] [Related]
18. Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Maes M; Kubera M; Uytterhoeven M; Vrydags N; Bosmans E Med Sci Monit; 2011 Apr; 17(4):SC11-5. PubMed ID: 21455120 [TBL] [Abstract][Full Text] [Related]
19. Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients. Fenouillet E; Vigouroux A; Steinberg JG; Chagvardieff A; Retornaz F; Guieu R; Jammes Y J Transl Med; 2016 Aug; 14(1):251. PubMed ID: 27580693 [TBL] [Abstract][Full Text] [Related]